For most families, medical treatments are something they hope will eventually end. But for ten-year-old Jessica and her family, each treatment represents something precious: another chance at life.
This week, Jessica reached an incredible milestone—her 244th life-saving infusion of Brineura. For years, this treatment has helped children diagnosed with CLN2 Batten disease live longer and experience moments that once seemed impossible.
But while Jessica’s milestone is worth celebrating, it now carries a painful new reality. Health officials recently announced that newly diagnosed children will no longer have access to the same treatment that gave Jessica her chance.
For many families, that news has been devastating.
A Diagnosis That Changes Everything
CLN2 Batten disease is a rare and devastating genetic disorder that primarily affects children. It slowly damages the brain and nervous system, leading to seizures, loss of motor skills, and a progressive decline in a child’s abilities.
For parents receiving this diagnosis, the news can feel overwhelming. The disease is rare, complex, and historically had very few treatment options.
For Jessica’s family, those early days were filled with fear and uncertainty. Like many parents, they searched desperately for anything that could help their daughter.
That search eventually led them to Brineura.
A Treatment That Changed the Future
Brineura became a breakthrough therapy for children with CLN2 Batten disease. While it is not a cure, the treatment can slow the progression of the illness, allowing children to maintain abilities and enjoy more time with their families.
Jessica began receiving the infusions years ago.
The treatment process is not simple. Each infusion requires careful medical supervision and preparation. It involves specialized procedures that deliver the medication directly where it is needed.
Yet for Jessica and her family, every infusion represents something powerful: hope.
Over time, those treatments began to add up.
Ten infusions.
Fifty infusions.
One hundred infusions.
And now, an extraordinary milestone—244.
Living Beyond Expectations
Today, Jessica is ten years old.
For many children diagnosed with CLN2 Batten disease in the past, reaching this age while maintaining quality of life was once far less likely. Treatments like Brineura have changed what families can hope for.
Jessica continues to smile through her treatments, surrounded by the love and support of her family and medical team.
Her life is filled with moments that once seemed uncertain—celebrations, laughter, and everyday experiences that families cherish.
Each infusion helps protect those moments.
A Celebration Shadowed by Heartbreak
But this week’s milestone arrived alongside heartbreaking news.
Health officials recently announced that newly diagnosed children will no longer be able to access Brineura, the very treatment that has helped Jessica reach this moment.
For families currently facing a new diagnosis of CLN2 Batten disease, the announcement has brought immense fear and sadness.
Many parents now worry that the treatment that gave Jessica hope may not be available for their own children.
The contrast is painful.
One child celebrating her 244th infusion.
Others facing the disease without access to the same opportunity.
The Emotional Weight of a Milestone
For Jessica’s family, this milestone is still deeply meaningful. Reaching 244 treatments is a testament to years of strength, dedication, and perseverance.
But it also carries a heavier emotional weight.
Every infusion reminds them not only of how far Jessica has come, but also of the families who may now face this devastating illness without the same support.
It turns what should be a purely joyful moment into something far more complicated.
A Story That Resonates Around the World
Stories like Jessica’s spread quickly because they touch something deeply human.
They remind people how fragile life can be. They highlight the importance of medical innovation and the life-changing impact treatments can have for rare diseases.
Most importantly, they reveal the strength of families who refuse to give up, even when facing overwhelming challenges.
Jessica’s journey represents hope, resilience, and the power of modern medicine.
But it also raises urgent questions about access to life-saving treatments.
Still Fighting, Still Smiling
Despite the difficult news surrounding the treatment, Jessica continues her journey the way she always has—with quiet courage.
She shows up for each infusion. She smiles through the process. She continues to live a life filled with moments that her family treasures.
Her story is not just about illness. It is about determination, love, and the belief that every child deserves a chance.
And as people learn about Jessica’s incredible milestone, one question continues to echo among families, doctors, and supporters everywhere:
If a treatment like Brineura can give children like Jessica more time, more life, and more hope—should any child facing CLN2 Batten disease be denied the same chance? 💔
Leave a Reply